| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/18/2007 | WO2007077464A3 Chicken virus vaccine and diagnostic |
| 10/18/2007 | WO2007075179A3 Bacteriophage-quantum dot (phage-qd) nanocomplex to detect biological targets in clinical and environmental isolates |
| 10/18/2007 | WO2002061054A3 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel |
| 10/18/2007 | US20070244043 Recombinant E-selectin made in insect cells |
| 10/18/2007 | US20070243615 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| 10/18/2007 | US20070243597 Disinfectant Solutions |
| 10/18/2007 | US20070243587 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus |
| 10/18/2007 | US20070243213 Hbv Variants Detection and Application |
| 10/18/2007 | US20070243208 Novel chimeric protein for prevention and treatment of hiv infection |
| 10/18/2007 | US20070243197 Dendrite Cells Transduced with Recombinant Adenovirus Advcea Which Generate Cea-Specific Cytotoxic T Lymphocytes, Vaccine and Pharmaceutical Composition Comprising the Same |
| 10/18/2007 | US20070243170 Targeting of Herpes Simplex Virus to Specific Receptors |
| 10/18/2007 | US20070243167 Novel Herpes Simplex Viruses |
| 10/18/2007 | CA2649182A1 Methods and compositions related to adenoassociated virus-phage particles |
| 10/18/2007 | CA2627952A1 Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 10/18/2007 | CA2613827A1 Growth of wild-type hepatitis a virus in cell culture |
| 10/17/2007 | EP1311289B1 Vaccines containing ribavirin |
| 10/17/2007 | EP1294892B1 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 10/17/2007 | EP1144006B1 CCR5 Antibody PA14 |
| 10/17/2007 | CN101056982A Mutant porcine reproductive and respiratory syndrome virus |
| 10/17/2007 | CN101056977A Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection |
| 10/17/2007 | CN101056976A Defective influenza virus particles |
| 10/17/2007 | CN101054419A Vectors with modified protease-dependent tropism |
| 10/16/2007 | US7282364 Expression cassette generated from these sequences; generating an immune response in a subject |
| 10/16/2007 | US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders |
| 10/16/2007 | CA2491918C Methods for detecting or assaying virus |
| 10/14/2007 | CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus |
| 10/11/2007 | WO2007114139A1 Phage display by novel filamentous bacteriophage |
| 10/11/2007 | WO2007038145A3 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 10/11/2007 | WO2007015704A3 Modified bacteriophage vectors and uses thereof |
| 10/11/2007 | WO2004056979A3 Recombinant virus production for the manufacturing of vaccines |
| 10/11/2007 | US20070240237 Pesticidal Vip3 toxins toxin from Bacillus thuringiensis highly active against a wide range of lepidopteran insect pests is disclosed. The DNA encoding the pesticidal toxin; used to transform various prokaryotic and eukaryotic organisms to express the pesticidal toxin;crops; genetic engineering |
| 10/11/2007 | DE10158523B4 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue |
| 10/10/2007 | EP1842561A1 Method and device for UV-inactivation of virus in blood products |
| 10/10/2007 | EP1841878A1 Method for the generation of virus producing cell lines and cell lines |
| 10/10/2007 | CN101052714A Stable and filterable enveloped virus formulations |
| 10/09/2007 | US7279555 Derived from duck hepatitis B virus core protein; haptens; gene therapy |
| 10/09/2007 | US7279333 Virus envelope vector for gene transfer |
| 10/09/2007 | US7279327 Methods for producing recombinant coronavirus |
| 10/09/2007 | US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups |
| 10/09/2007 | US7279306 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof |
| 10/09/2007 | US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 10/04/2007 | WO2007084767A3 Methods for profiling transcriptosomes |
| 10/04/2007 | WO2007048086A3 Canine influenza virus and related compositions and methods of use |
| 10/04/2007 | WO2007035856A3 Systems for detection and production of respiratory, herpes and enteric viruses |
| 10/04/2007 | US20070232790 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 10/04/2007 | US20070232645 Anti-viral compounds |
| 10/04/2007 | US20070232627 Anti-viral compounds |
| 10/04/2007 | US20070231875 Apparatus for the Disruption of Animal Cells |
| 10/04/2007 | US20070231350 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 10/04/2007 | US20070231349 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 10/04/2007 | US20070231348 High titer recombinant influenza viruses for vaccines |
| 10/04/2007 | US20070231303 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 10/03/2007 | EP1840214A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 10/03/2007 | EP1840209A2 Adeno-associated virus vectors and use thereof |
| 10/03/2007 | EP1839672A2 Modified vaccinia virus Ankara for the vaccination of neonates |
| 10/03/2007 | EP1839061A2 Method for the specific or unspecific separation of cells and/or viruses from aqueous media and use thereof |
| 10/03/2007 | EP1838847A1 Plant virus designated tomato torrado virus |
| 10/03/2007 | EP1543113B1 Chicken astrovirus type 2 |
| 10/03/2007 | EP1100942B1 Herpes virus vectors for dendritic cells |
| 10/03/2007 | CN101048502A Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 10/03/2007 | CN101048498A Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 10/03/2007 | CN101045917A Swine reproduction and respiration syndrome vaccine and its prepn process and application |
| 10/03/2007 | CN101045748A HIV protease substrate molecular with evolution immune globulin binding molecular, preparation method and application thereof |
| 10/02/2007 | US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 10/02/2007 | US7276333 Viral infection inhibitor targeting integrase N-terminal domain |
| 10/02/2007 | US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol. |
| 10/02/2007 | US7276234 Introducing a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes, and expressing the foreign DNA in the thymus during differentiation and maturation of the fetal immature T lymphocyte to reconstitute the immune system |
| 09/27/2007 | WO2007108005A1 Chimeric tymovirus-like particles |
| 09/27/2007 | WO2007038276A3 Dna modular cloning vector plasmids and methods for their use |
| 09/27/2007 | US20070224679 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 09/27/2007 | US20070224633 Muteins of Tear Lipocalin |
| 09/27/2007 | US20070224218 Viral antigens |
| 09/27/2007 | US20070224206 Inactivating Organisms Using Carbon Dioxide at or Near its Supercritical Pressure and Temperature Conditions |
| 09/27/2007 | US20070224195 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 09/26/2007 | EP1836300A1 Cancer-targeted viral vectors |
| 09/26/2007 | EP1836295A1 Virus recovery medium, use thereof and viral diagnostic kit including same |
| 09/26/2007 | EP1706485B1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044237A Method for preparing viral material |
| 09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
| 09/25/2007 | US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53. |
| 09/25/2007 | US7273617 Vaccines |
| 09/25/2007 | US7273616 Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof |
| 09/25/2007 | US7273605 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 09/25/2007 | CA2503774C Improvements in virus production |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2183758C Human papilloma virus detection in a nucleic acid amplification process using general primers |
| 09/20/2007 | WO2007106050A1 Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody |
| 09/20/2007 | WO2007105744A1 Purkinje cell-tropic viral vector |
| 09/20/2007 | WO2007104979A1 Virus-like particles of rift valley fever virus |
| 09/20/2007 | WO2007104581A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 09/20/2007 | WO2007058527A3 Inducible expression systems |
| 09/20/2007 | US20070218536 Polyvalent Viral Vectors and a System for Production Thereof |
| 09/20/2007 | US20070218078 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 09/20/2007 | US20070218074 Vaccine mixture comprising e6/e7 human papilloma viral amino acid sequences for use as therapeutic targeting tools in treatment of uterine cancer |
| 09/19/2007 | EP1835031A1 Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans |
| 09/19/2007 | EP1833992A2 Pcv2 immunogenic compositions and methods of producing such compositions |
| 09/19/2007 | EP1833989A1 Virus preparations and methods |
| 09/19/2007 | EP1833508A2 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |